Selpercatinib | Potent and selective RET kinase inhibitor
Available Options
| Size: | Price | Quantity | |
|---|---|---|---|
| 5 mg | $45.00 | ||
| 25 mg | $150.00 |
Selpercatinib (2152628-33-4) is a potent (IC50 = 0.45 nM)1 and selective inhibitor of RET kinase.2 Clinically relevant for the treatment of RET-altered non-small cell lung cancer3 and certain thyroid cancers4.
References/Citations:
- Kooijman et al. (2022); Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020, Front. Oncol., 12 953013
- Subbiah et al. (2018), Selective RET kinase inhibition for patients with RET-altered cancers; Ann. Oncol. 29 1869
- Drilon et al. (2020); Efficacy of Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancer, N. Engl. J. Med., 383 813
- Wirth et al. (2020); Efficacy of Selpercatinib in RET-Altered Thyroid Cancer, N. Engl. J. Med., 383 825
C29H31N7O3
>98% by HPLC
NMR: (Conforms)
Safety Data Sheet:
Product Data Sheet:
Materials provided by Focus Biomolecules are for laboratory research use only and are not intended for human or veterinary applications. Please note that we do not sell to individuals and that all orders placed by non-research organizations will incur a $20 restocking/refund fee
Selpercatinib (2152628-33-4) is a potent (IC50 = 0.45 nM)1 and selective inhibitor of RET kinase.2 Clinically relevant for the treatment of RET-altered non-small cell lung cancer3 and certain thyroid cancers4.
References/Citations:
- Kooijman et al. (2022); Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020, Front. Oncol., 12 953013
- Subbiah et al. (2018), Selective RET kinase inhibition for patients with RET-altered cancers; Ann. Oncol. 29 1869
- Drilon et al. (2020); Efficacy of Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancer, N. Engl. J. Med., 383 813
- Wirth et al. (2020); Efficacy of Selpercatinib in RET-Altered Thyroid Cancer, N. Engl. J. Med., 383 825
Related products
-
NU7441 | DNA-PK inhibitor
From $50.00CAS:503468-95-9Catalog Number:10-4810Activity:DNA-PK inhibitorChemical Name:8-Dibenzothiophen-4-yl-2-morpholin-4-ylchromen-4-oneAlternate Name:Ku-57788Molecular Weight:413.49Molecular Formula:C25H19NO3SSolubility:Soluble in DMSO (up to 10 mg/ml with warming).Physical Properties:Off-white to beige solidPurity:98% by TLC
NMR (Conforms)Storage Temperature:-20°Stability:Stable for 1 year as supplied. Solutions in DMSO may be stored at -20° for up to 3 months.Shipping Code:RT -
Elafibranor | PPARalpha/delta agonist
From $65.00CAS:923978-27-2Catalog Number:10-3901Activity:PPARalpha/delta agonistChemical Name:2-[2,6-Dimethyl-4-[(E)-3-(4-methylsulfanylphenyl)-3-oxoprop-1-enyl]phenoxy]-2-methylpropanoic acidAlternate Name:GFT505Molecular Weight:384.49Molecular Formula:C22H24O4SSolubility:Soluble in DMSO (up to at least 25 mg/ml).Physical Properties:Pale yellow solidPurity:98% by HPLC
NMR (Conforms)Storage Temperature:-20°Stability:Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 1 month.Shipping Code:RT -
PNU 74654 | Wnt pathway blocker
From $55.00CAS:113906-27-7Catalog Number:10-4519Activity:Wnt pathway blockerChemical Name:2-Phenoxybenzoic acid [(5-methyl-2-furanyl)methylene]hydrazideMolecular Weight:320.35Molecular Formula:C19H16N2O3Solubility:Soluble in DMSO (up to 25 mg/ml).Physical Properties:Off-white solidPurity:>98% by TLC
NMR (conforms)Storage Temperature:-20°Stability:Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 3 months.Shipping Code:RT
Calculate the molar concentration, mass or volume in a solution.
Concentration × Volume × Molecular Weight = Mass
Focus Biomolecules • Plymouth Meeting, PA USA • 1-855-FOCUS21
Focus Biomolecules
Plymouth Meeting, PA USA
1-855-FOCUS21
Website Created by Advanta Advertising LLC.